Disclosed are a pharmaceutical product having excellent adiponectin production ability, and food useful for the pharmaceutical product. The pharmaceutical product contains, as active ingredients, a sugar having a polymerisation degree of 2-10, wherein mannose units account for not less than 50% based on the number, and a chlorogenic acid.